Glass House uplists medical cannabis to NYSE
Glass House uplists medical cannabis to NYSE after shifting to medical-only model; shares rose, valuation hit $1B, and company appeals a $21,000 state fine.
Tag: NYSE
Jim Cramer Backs trulieve cannabis as ‘Terrific Spec’
Jim Cramer calls trulieve cannabis a ‘terrific spec’ and praises its brand. TRLV operates dispensaries and home delivery for flower, concentrates and
Trulieve lists on NYSE as first U.S. cannabis company
Trulieve’s nyse listing gives U.S. investors direct access to TRLV shares, boosts liquidity and signals federal change after Schedule III reclassification.
Trulieve lists on NYSE after federal reclassification
Trulieve’s nyse listing follows Schedule III reclassification, opening U.S. markets to medical operations while debt, price pressure and state risks